Published in Heart Rhythm on November 01, 2004
Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study. BMJ (2014) 4.23
QTc interval prolongation in patients with HIV and AIDS. J Natl Med Assoc (2005) 1.09
Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period. Br J Clin Pharmacol (2008) 0.92
Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms. Nat Rev Cardiol (2015) 0.90
QTc interval prolongation in HIV-infected patients: a case-control study by 24-hour Holter ECG recording. BMC Cardiovasc Disord (2012) 0.81
Fluoroquinolone-induced serious, persistent, multisymptom adverse effects. BMJ Case Rep (2015) 0.75
Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med (2013) 6.40
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation (2004) 4.04
Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med (2006) 3.59
Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation (2012) 2.53
Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA (2006) 2.50
Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation (2013) 2.30
Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation (2011) 2.23
Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail (2012) 2.13
Inaccessibility to quinidine therapy is about to get worse. J Am Coll Cardiol (2013) 2.12
Atrial response to ventricular antitachycardia pacing discriminates mechanism of 1:1 atrioventricular tachycardia. J Cardiovasc Electrophysiol (2005) 2.10
Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm (2005) 2.07
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89
Asymptomatic Wolff-Parkinson-White syndrome: is it time to revisit guidelines? J Am Coll Cardiol (2003) 1.86
Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med (2012) 1.80
Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up. Heart Rhythm (2008) 1.77
Current of injury predicts acute performance of catheter-delivered active fixation pacing leads. Pacing Clin Electrophysiol (2007) 1.73
Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm (2011) 1.73
A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope. Am J Med (2003) 1.69
A novel pacing maneuver to localize focal atrial tachycardia. J Cardiovasc Electrophysiol (2006) 1.64
Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace (2012) 1.64
Images in cardiovascular medicine. A sensitive dissection: profound bradycardia complicating carotid dissection. Circulation (2008) 1.60
Congenital and acquired long QT syndromes. Can J Cardiol (2003) 1.59
Laser lead extraction: is there a learning curve? Pacing Clin Electrophysiol (2005) 1.59
Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope. BMC Health Serv Res (2006) 1.58
Age of first faint in patients with vasovagal syncope. J Cardiovasc Electrophysiol (2006) 1.52
Differential ventricular entrainment: a maneuver to differentiate AV node reentrant tachycardia from orthodromic reciprocating tachycardia. Heart Rhythm (2009) 1.52
Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee. Circulation (2012) 1.49
Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol (2010) 1.48
Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: a meta-analysis. Circulation (2012) 1.48
Standardized approaches to the investigation of syncope: Canadian Cardiovascular Society position paper. Can J Cardiol (2011) 1.47
End-recovery QTc: a useful metric for assessing genetic variants of unknown significance in long-QT syndrome. J Cardiovasc Electrophysiol (2012) 1.44
Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure. Can J Cardiol (2005) 1.43
Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue. Circulation (2010) 1.42
Isolation of pulmonary veins using a transvenous curvilinear cryoablation catheter: feasibility, initial experience, and analysis of recurrences. J Cardiovasc Electrophysiol (2005) 1.42
Scope and nature of sudden cardiac death before age 40 in Ontario: a report from the cardiac death advisory committee of the office of the chief coroner. Heart Rhythm (2012) 1.42
Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol (2010) 1.41
The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device Committee. Heart Rhythm (2013) 1.41
Incidence of atrial fibrillation and prevalence of intermittent pre-excitation in asymptomatic Wolff-Parkinson-White patients: a meta-analysis. Int J Cardiol (2012) 1.40
Images in electrophysiology: latent pacemaker infection. J Cardiovasc Electrophysiol (2006) 1.38
Tachycardia with VA dissociation: an unusual tachycardia mechanism. J Cardiovasc Electrophysiol (2005) 1.37
Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia. Heart Rhythm (2006) 1.27
The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med (2007) 1.27
Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging (2012) 1.24
Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis. Heart Rhythm (2006) 1.22
Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation: electrophysiological and pathological data from patients undergoing atrial fibrillation surgery. Circulation (2003) 1.20
Sudden cardiac arrest without overt heart disease. Circulation (2011) 1.15
Prevalence and characteristics of early repolarization in the CASPER registry: cardiac arrest survivors with preserved ejection fraction registry. J Am Coll Cardiol (2011) 1.13
WPW pattern in the asymptomatic individual: has anything changed? Circ Arrhythm Electrophysiol (2009) 1.13
Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm (2009) 1.12
Cavotricuspid isthmus conduction is dependent on underlying anatomic bundle architecture: observations using a maximum voltage-guided ablation technique. J Cardiovasc Electrophysiol (2006) 1.12
Esophageal temperature monitoring during radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2005) 1.10
Impact of routine transoesophageal echocardiography on safety, outcomes, and cost of pulmonary vein ablation: inferences drawn from a decision analysis model. Europace (2010) 1.08
Rapid ablation for atrial flutter by targeting maximum voltage-factors associated with short ablation times. J Cardiovasc Electrophysiol (2007) 1.07
Is ambulatory monitoring for "community-acquired" syncope economically attractive? A cost-effectiveness analysis of a randomized trial of external loop recorders versus Holter monitoring. Am Heart J (2005) 1.05
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results. Card Electrophysiol Rev (2003) 1.05
Cryoablation of atrial arrhythmias. Card Electrophysiol Rev (2002) 1.01
Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin. Am Heart J (2009) 0.99
Utility of treadmill testing in identification and genotype prediction in long-QT syndrome. Circ Arrhythm Electrophysiol (2010) 0.99
QT prolongation and monomorphic VT caused by pheochromocytoma. J Cardiovasc Electrophysiol (2009) 0.98
A clinical approach to early repolarization. Circulation (2013) 0.98
Heart rate variability in obstructive sleep apnea: a prospective study and frequency domain analysis. Ann Noninvasive Electrocardiol (2003) 0.97
An electrocardiographic scoring system for distinguishing right ventricular outflow tract arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy from idiopathic ventricular tachycardia. Heart Rhythm (2012) 0.96
When should we recommend catheter ablation for patients with the Wolff-Parkinson-White syndrome? Curr Opin Cardiol (2008) 0.94
Predicting the cause of syncope from clinical history in patients undergoing prolonged monitoring. Heart Rhythm (2008) 0.94
Ten-year follow-up of cardiac sympathectomy in a young woman with catecholaminergic polymorphic ventricular tachycardia and an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol (2009) 0.94
Age-dependent effect of β-blockers in preventing vasovagal syncope. Circ Arrhythm Electrophysiol (2012) 0.93
External loop recorders: determinants of diagnostic yield in patients with syncope. Am Heart J (2004) 0.92
Sex differences in QTc interval and QT dispersion: dynamics during exercise and recovery in healthy subjects. Am Heart J (2002) 0.92
Effect of change in posture and exercise on repolarization in patients with long QT syndrome with HERG channel mutations. Can J Cardiol (2005) 0.92
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J (2008) 0.92
Utility and cost effectiveness of temporary pacing using active fixation leads and an externally placed reusable permanent pacemaker. Am J Cardiol (2006) 0.91
Supraventricular tachycardia: diagnosis and management. Mayo Clin Proc (2008) 0.91
Design and implementation of a population-based registry of Implantable Cardioverter Defibrillators (ICDs) in Ontario. Heart Rhythm (2008) 0.91
Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope. Europace (2007) 0.90
TMEM43 mutations associated with arrhythmogenic right ventricular cardiomyopathy in non-Newfoundland populations. Hum Genet (2013) 0.90
Images in cardiovascular medicine. Pacemaker implantation in a patient with dextrocardia, corrected transposition, and situs inversus. Circulation (2007) 0.89
Influence of pacing site characteristics on response to cardiac resynchronization therapy. Circ Cardiovasc Imaging (2013) 0.89
The effect of electronic repositioning on left ventricular pacing and phrenic nerve stimulation. Europace (2011) 0.88
Survival rates as a guide to implanted cardioverter-defibrillator replacement strategies for device recalls--adding statistical insight to clinical intuition. Am Heart J (2007) 0.88
Torsades de pointes during complete atrioventricular block: Genetic factors and electrocardiogram correlates. Can J Cardiol (2010) 0.88
Reduction of complex ventricular ectopy and improvement in exercise capacity with flecainide therapy in Andersen-Tawil syndrome. Europace (2008) 0.87
Safety and feasibility of cryothermal ablation within the mid- and distal coronary sinus. J Cardiovasc Electrophysiol (2004) 0.87
Is defibrillation testing still necessary? A decision analysis and Markov model. J Cardiovasc Electrophysiol (2008) 0.87
Reduction in atrial flutter ablation time by targeting maximum voltage: results of a prospective randomized clinical trial. J Cardiovasc Electrophysiol (2009) 0.87
Does adenosine response predict clinical recurrence of atrial fibrillation after pulmonary vein isolation? J Cardiovasc Electrophysiol (2011) 0.87
Exercise testing: the catecholaminergic polymorphic ventricular tachycardia crystal ball? Europace (2012) 0.86
Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol (2013) 0.86
Noninvasive assessment of atrial substrate change after wide area circumferential ablation: a comparison with segmental pulmonary vein isolation. Ann Noninvasive Electrocardiol (2007) 0.85
Randomized cluster crossover trials for reliable, efficient, comparative effectiveness testing: design of the Prevention of Arrhythmia Device Infection Trial (PADIT). Can J Cardiol (2013) 0.85
Utility of the recovery electrocardiogram after exercise: a novel indicator for the diagnosis and genotyping of long QT syndrome? Heart Rhythm (2010) 0.85
Voltage-guided ablation technique for cavotricuspid isthmus-dependent atrial flutter: refining the continuous line. J Cardiovasc Electrophysiol (2012) 0.85
Further evidence for the "muscle bundle" hypothesis of cavotricuspid isthmus conduction: physiological proof, with clinical implications for ablation. J Cardiovasc Electrophysiol (2012) 0.85
Ventricular fibrillation induced by spontaneous hypothermia in a patient with early repolarization syndrome. J Cardiovasc Electrophysiol (2012) 0.85
Sudden intense exercise increases QT heart rate slope and T wave complexity in long QT syndrome and normal subjects. Pacing Clin Electrophysiol (2004) 0.84
Elimination of cavotricuspid isthmus conduction by a single ablation lesion: observations from a maximum voltage-guided ablation technique. Europace (2007) 0.84
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. J Am Coll Cardiol (2017) 0.83
Feasibility of magnetic resonance imaging in patients with an implantable loop recorder. Pacing Clin Electrophysiol (2008) 0.83
Complete antral encirclement is not required for pulmonary vein isolation. Heart Rhythm (2010) 0.83
Optimal pacing for symptomatic AV block: a comparison of VDD and DDD pacing. Pacing Clin Electrophysiol (2004) 0.82
Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation. Am Heart J (2006) 0.82